Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-4 of 4
Keywords: Hepatocellular carcinoma (HCC)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2023) 137 (4): 303–316.
Published: 17 February 2023
...Jing-Xuan Xu; Shui-Lin Qin; Hao-Wen Wei; Yuan-Yuan Chen; Yu-Chong Peng; Lu-Nan Qi Background: Postoperative transarterial chemoembolization (PA-TACE) is an effective adjuvant therapy for preventing early postoperative recurrence of hepatocellular carcinoma (HCC); however, many patients...
Includes: Supplementary data
Articles
Teng Feng, Johanna Dzieran, Xing Gu, Silke Marhenke, Arndt Vogel, Keigo Machida, Thomas S. Weiss, Petra Ruemmele, Otto Kollmar, Patrick Hoffmann, Friedrich Grässer, Heike Allgayer, Jasmin Fabian, Hong Lei Weng, Andreas Teufel, Thorsten Maass, Christoph Meyer, Ulrich Lehmann, Cheng Zhu, Peter R. Mertens, Chun Fang Gao, Steven Dooley, Nadja M. Meindl-Beinker
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (11): 761–774.
Published: 17 March 2015
... promoter. In the present study, we investigate Smad7 overexpression as a pathophysiological mechanism for cytostatic TGF-β inhibition in liver damage and hepatocellular carcinoma (HCC). Transgenic hepatocyte-specific Smad7 overexpression in damaged liver of fumarylacetoacetate hydrolase (FAH)-deficient...
Includes: Supplementary data
Articles
Jan Peveling-Oberhag, Claudia Döring, Sylvia Hartmann, Natalie Filmann, Angelika Mertens, Albrecht Piiper, Eva Herrmann, Martin-Leo Hansmann, Stefan Zeuzem, Jörg Trojan, Martin-Walter Welker
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (1): 29–37.
Published: 27 August 2014
...Jan Peveling-Oberhag; Claudia Döring; Sylvia Hartmann; Natalie Filmann; Angelika Mertens; Albrecht Piiper; Eva Herrmann; Martin-Leo Hansmann; Stefan Zeuzem; Jörg Trojan; Martin-Walter Welker Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC). However...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (7): 467–477.
Published: 29 February 2008
... importance of inhibitors of angiogenesis in HCC therapy. © The Authors Journal compilation © 2008 Biochemical Society 2008 angiogenesis growth factor hepatocellular carcinoma (HCC) inflammation liver vascular endothelial growth factor (VEGF) COX-2 (cyclo-oxygenase-2) expression...
